Category:

Non-Life

Insurers fret as company bosses face coronavirus legal claims

“An uptick in litigation targeting directors and officers across industry sectors is one likely, and unwelcome, consequence” of the coronavirus pandemic, said James Whitaker, partner at law firm Mayer Brown.

“We are starting to see insurers looking at the potential for specific COVID-19 exclusions going forward,” said Beth Thurston, head of management liability, UK & Ireland, for broker Marsh.

read more

EU states step in where trade credit insurers fear to tread

Without insurance, companies can be reluctant to buy or sell goods or services to others, with a rise in insolvencies expected among European firms forced to halt operations due to lockdowns aimed at slowing the coronavirus pandemic’s spread.

Atradius, which like rivals Coface and Euler Hermes sells protection to companies against the risk of default by their customers, forecasts a 2.1% rise in insolvencies in western Europe this year, compared with a 0.2% fall in 2019.

read more

ICICI Gen and Bharat Pe partner to launch Coronavirus cover for shopkeepers

On a diagnosis of COVID-19 (+ve),  the policy holder will paid  be 100% of the sum insured, irrespective of hospitalization expenses.

The health cover is priced affordably at a premium starting at nominal amount of ₹ 199 and provides a sum insured for₹ 25,000 and value-added benefits such as Health Assistance and CHAT/Virtual assistance, teleconsultation and ambulance assistance, as part of the offering. The unique benefit of the COVID-19 Insurance Protection Cover is the coverage across the age group of 18-65 years.

read more

IRDA bans Capital Gearing treaties by insurers

Insurers who are having such treaties on their books as on the date of issuance of this circular shall take the following  steps-

 -Submit board approved action plan to the IRDAI on or before 30th June, 2020 for phasing out the treaties along with timelines such that it complies with the Solvency Stipulations. 

-The plan of action will also  include assessment of requirement of  capital infusion and sources of funds for the capital infusion so required due to prospective closure of these Capital Gearing treaties.

read more